chrX-151738589-A-G

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_005140.3(CNGA2):ā€‹c.106A>Gā€‹(p.Ser36Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,200,351 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 63 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000045 ( 0 hom., 1 hem., cov: 23)
Exomes š‘“: 0.00012 ( 0 hom. 62 hem. )

Consequence

CNGA2
NM_005140.3 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 3.05
Variant links:
Genes affected
CNGA2 (HGNC:2149): (cyclic nucleotide gated channel subunit alpha 2) The protein encoded by this gene represents the alpha subunit of a cyclic nucleotide-gated olfactory channel. The encoded protein contains a carboxy-terminal leucine zipper that mediates channel formation. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09329641).
BP6
Variant X-151738589-A-G is Benign according to our data. Variant chrX-151738589-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2590515.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High Hemizygotes in GnomAdExome4 at 62 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CNGA2NM_005140.3 linkc.106A>G p.Ser36Gly missense_variant 2/7 ENST00000329903.5 NP_005131.1 Q16280B3KXY3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CNGA2ENST00000329903.5 linkc.106A>G p.Ser36Gly missense_variant 2/75 NM_005140.3 ENSP00000328478.4 Q16280

Frequencies

GnomAD3 genomes
AF:
0.0000446
AC:
5
AN:
112174
Hom.:
0
Cov.:
23
AF XY:
0.0000291
AC XY:
1
AN XY:
34318
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000373
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000752
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000110
AC:
20
AN:
182262
Hom.:
0
AF XY:
0.000195
AC XY:
13
AN XY:
66738
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000732
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000427
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000111
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.000121
AC:
132
AN:
1088123
Hom.:
0
Cov.:
28
AF XY:
0.000175
AC XY:
62
AN XY:
353717
show subpopulations
Gnomad4 AFR exome
AF:
0.0000763
Gnomad4 AMR exome
AF:
0.000142
Gnomad4 ASJ exome
AF:
0.0000518
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000503
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000101
Gnomad4 OTH exome
AF:
0.000109
GnomAD4 genome
AF:
0.0000446
AC:
5
AN:
112228
Hom.:
0
Cov.:
23
AF XY:
0.0000291
AC XY:
1
AN XY:
34382
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000374
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000752
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000135
Hom.:
5
Bravo
AF:
0.0000869
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000148
AC:
18

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 13, 2023The c.106A>G (p.S36G) alteration is located in exon 2 (coding exon 1) of the CNGA2 gene. This alteration results from a A to G substitution at nucleotide position 106, causing the serine (S) at amino acid position 36 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2023CNGA2: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.65
T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.093
T
MetaSVM
Uncertain
0.051
D
MutationAssessor
Benign
2.0
M
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.040
N
REVEL
Uncertain
0.31
Sift
Benign
0.089
T
Sift4G
Benign
0.20
T
Polyphen
0.0050
B
Vest4
0.031
MVP
0.82
MPC
0.063
ClinPred
0.043
T
GERP RS
4.8
Varity_R
0.10
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200529056; hg19: chrX-150907061; API